NCT00535418已完成2 期
Pre-operative Hormone Therapy for Postmenopausal Women With ER and/or PgR Positive Breast Cancer: An Uncontrolled Phase IIb/III Trial to Assess Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 35
研究概览
简要总结
This study will assess optimal duration of pre-operative treatment with letrozole and to correlate clinical efficacy with appropriate surrogate markers.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Letrozole
Experimental
干预措施: Letrozole (Drug)
研究者
相似试验
已完成
2 期
Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast CancerBreast Cancer FemaleNCT03747042University of Texas Southwestern Medical Center61
已完成
2 期
Neoadjuvant Endocrine Therapy in Breast CancerHighly Endocrine Responsive Operable Breast CancerNCT03397537Guangdong Provincial People's Hospital46
进行中（未招募）
不适用
Preoperative hormone therapy for pre- and postmenopausal women with ER positive breast cancer: A double blind randomized parallel group phase II trial, comparing the effect of 2 weeks of preoperative Estetrol with placebo - Preoperative estetrolbreast cancerEUCTR2006-006542-34-ATPantarhei Bioscience B.V.
终止
早期 1 期
Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by SurgeryBreast CancerNCT00651976Vanderbilt-Ingram Cancer Center213
已完成
2 期
Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast CancerPostmenopausal Women With Advanced Breast CancerNCT00237211Novartis Pharmaceuticals31